Securian Asset Management, Inc Organon & Co. Transaction History

Securian Asset Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$16.59 - $23.77 $40,512 - $58,046	-2,442 Reduced 11.77%	18,301 $317,000
Q2 2023 Aug 07, 2023	SELL	$19.27 - $24.63 $4,258 - $5,443	-221 Reduced 1.05%	20,743 $431,000
Q1 2023 Apr 27, 2023	BUY	$21.42 - $32.08 $2,913 - $4,362	136 Added 0.65%	20,964 $493,000
Q4 2022 Feb 02, 2023	BUY	$23.31 - $28.61 $3,846 - $4,720	165 Added 0.8%	20,828 $581,000
Q3 2022 Oct 28, 2022	BUY	$23.4 - $34.25 $6,598 - $9,658	282 Added 1.38%	20,663 $484,000
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $3,166 - $3,890	-100 Reduced 0.49%	20,381 $688,000
Q1 2022 May 03, 2022	SELL	$30.45 - $39.36 $12,180 - $15,744	-400 Reduced 1.92%	20,481 $715,000
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $15,195 - $19,678	-530 Reduced 2.48%	20,881 $636,000
Q3 2021 Nov 08, 2021	BUY	$28.63 - $35.64 $612,996 - $763,088	21,411 New	21,411 $702,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Securian Asset Management, Inc with notifications on news.